ERG and acute myeloid leukemia: It has been demonstrated that allo-HSCT improves the prognosis of FUS-ERG positive AML patients.[28] In our case, neither the conventional standard chemotherapy regimen nor the combination of chemotherapy and targeted agents failed to achieve CR.